Cargando…

Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in Trp53+/- mice

Detalles Bibliográficos
Autores principales:	Blackburn, AC, Rooke, M, Li, Y, Dahlstrom, JE, Board, PG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326716/ http://dx.doi.org/10.1186/1897-4287-10-S2-A62

Ejemplares similares

Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in the Li-Fraumeni Syndrome model, Trp53(+/-) mice
por: Blackburn, Anneke C, et al.
Publicado: (2014)

Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
por: Sun, Ramon C, et al.
Publicado: (2011)

Contribution of genetic variation within SuprMam1 and SuprMam2 to breast cancer susceptibility
por: Ratnadiwakara, M, et al.
Publicado: (2012)

Dichloroacetate is an effective treatment for sarcoma models in vitro and in vivo
por: Rooke, Melissa, et al.
Publicado: (2014)

The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/–) and Trp53(−/−) mice
por: Krais, Annette M., et al.
Publicado: (2015)

Activation of LINE-1 Retrotransposon Increases the Risk of Epithelial-Mesenchymal Transition and Metastasis in Epithelial Cancer
por: Rangasamy, D., et al.
Publicado: (2015)

Bowel cancer chemoprevention - ready for the clinic?
por: Burn, J
Publicado: (2012)

Intraductal assessment to determine response to chemopreventive interventions
por: Sauter, ER
Publicado: (2009)

Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?
por: Blackburn, Anneke C, et al.
Publicado: (2002)

Hormonal control of p53 and chemoprevention
por: Jerry, D Joseph, et al.
Publicado: (2002)

Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells
por: Li, Bo, et al.
Publicado: (2016)

PW02-035 - A role for thermo-TRP channels in innate immunity?
por: Stoffels, M, et al.
Publicado: (2013)

Selecting women for breast cancer chemoprevention and what agents should be used
por: Cuzick, J
Publicado: (2012)

Anaerobic Microbial Metabolism of Dichloroacetate
por: Chen, Gao, et al.
Publicado: (2021)

Breast Cancer Metabolism and Mitochondrial Activity: The Possibility of Chemoprevention with Metformin
por: Cazzaniga, Massimiliano, et al.
Publicado: (2015)

The GSTT1 genotype is associated with p53 mutation status of breast cancer tumours
por: Gudmundsdóttir, K, et al.
Publicado: (2000)

Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells
por: Florio, Rosalba, et al.
Publicado: (2018)

Long-term stabilization of metastatic melanoma with sodium dichloroacetate
por: Khan, Akbar, et al.
Publicado: (2017)

Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53(+/- )mice
por: Dunphy, Karen A, et al.
Publicado: (2008)

Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity
por: van der Weyden, L, et al.
Publicado: (2013)

Dichloroacetate treatment improves mitochondrial metabolism and reduces brain injury in neonatal mice
por: Sun, Yanyan, et al.
Publicado: (2016)

Chemopreventive Effect of Metformin on Gastric Cancer Development
por: Cheung, Ka Shing, et al.
Publicado: (2022)

Targeting p53 by small molecule p53 activators in multiple myeloma
por: Saha, Manujendra N, et al.
Publicado: (2012)

Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
por: Kim, Tae Suk, et al.
Publicado: (2021)

Nucks1 synergizes with Trp53 to promote radiation lymphomagenesis in mice
por: Yue, Yangbo, et al.
Publicado: (2016)

Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction
por: Mainali, Rabina, et al.
Publicado: (2021)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Activity of semicarbazide-sensitive amine oxidase in guinea-pig tissues is not affected by metformin
por: Lukan, Katja, et al.
Publicado: (2012)

Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related?
por: McAllister, Kimberly A, et al.
Publicado: (2002)

Metformin improves IK(Ca)-mediated endothelial dilative dysfunction of arteriole in diabetic rats
por: Zhao, Li-Mei, et al.
Publicado: (2012)

Loss of TRP53 (p53) accelerates tumorigenesis and changes the tumor spectrum of SJL/J mice
por: Branca, Jane A, et al.
Publicado: (2020)

Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
por: Albers, Joachim, et al.
Publicado: (2013)

Haploinsufficiency of Trp53 dramatically extends the lifespan of Sirt6-deficient mice
por: Ghosh, Shrestha, et al.
Publicado: (2018)

IKKbeta and p53 as therapeutic targets for arthritis
por: Tak, PP
Publicado: (2001)

Metformin treatment improves vascular function in rats with neonatal streptozotocin-induced type 2 diabetes
por: Sartoretto, JL, et al.
Publicado: (2003)

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
por: Michelakis, E D, et al.
Publicado: (2008)

Metabolic Response of Pancreatic Carcinoma Cells under Treatment with Dichloroacetate
por: Feuerecker, Benedikt, et al.
Publicado: (2021)

Clinical pharmacology and toxicology of dichloroacetate.
por: Stacpoole, P W, et al.
Publicado: (1998)

Long-term stabilization of stage 4 colon cancer using sodium dichloroacetate therapy
por: Khan, Akbar, et al.
Publicado: (2016)

Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice
por: Epstein, Richard J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2efdv4vopnnn9p46bd14boiliv